Loading data
BMRNasdaq
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 3.09 m USD | 3.06 m USD | 2.91 m USD | 2.86 m USD | 3.3 m USD |
| Cost of revenue | 318 k USD | 240 k USD | 96 k USD | 98 k USD | 90 k USD |
| Gross profit | 2.78 m USD | 2.82 m USD | 2.81 m USD | 2.77 m USD | 3.21 m USD |
| Research and development expense | 4.6 m USD | 2.89 m USD | 1.82 m USD | 2.06 m USD | 2.03 m USD |
| Operating profit | -6.45 m USD | -3.22 m USD | -878 k USD | -1.03 m USD | -425 k USD |
| Profit before tax | -6.01 m USD | -3.31 m USD | -656 k USD | -1.2 m USD | -900 k USD |
| Income tax expense | 15 k USD | 46 k USD | 39 k USD | 52 k USD | 52 k USD |
| Net income (reported basis) | -6.02 m USD | -3.35 m USD | -695 k USD | -1.25 m USD | -952 k USD |
| Net income attributable to common shareholders | -6.02 m USD | -3.35 m USD | -702 k USD | -1.25 m USD | — |
| Basic earnings per share | -0.39 USD/share | -0.22 USD/share | -0.06 USD/share | -0.48 USD/share | -0.37 USD/share |
| Diluted earnings per share | -0.39 USD/share | -0.22 USD/share | -0.09 USD/share | -0.48 USD/share | -0.37 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.